about
P1889
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerProtein Profiling of Bladder Urothelial Cell CarcinomaIntracranial tuberculoma in a liver transplant patient: first reported case and review of the literature.Pathway-based analysis of breast cancer.Protein signature for non-small cell lung cancer prognosis.Fibrosis-dependent mechanisms of hepatocarcinogenesisDetection of Chlamydia trachomatis by isothermal ramification amplification method: a feasibility study.Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.Use of ramification amplification assay for detection of Escherichia coli O157:H7 and other E. coli Shiga toxin-producing strains.Biomarkers for bladder cancer management: present and future.Protein profiling of preeclampsia placental tissuesMolecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.BRD4 inhibitor inhibits colorectal cancer growth and metastasis.Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach.Global profiling of signaling networks: study of breast cancer stem cells and potential regulation.Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Induction and contribution of beta platelet-derived growth factor signalling by hepatic stellate cells to liver regeneration after partial hepatectomy in mice.Serum biomarker panels for diagnosis of gastric cancer.Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion.Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma.Proteomics, pathway array and signaling network-based medicine in cancer.Detection of genetic variations in coagulopathy-related genes using ramified rolling circle amplification.Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.Signaling proteins and pathways affected by flavonoids in leukemia cells.IL-1β induces IL-6 production in retinal Müller cells predominantly through the activation of p38 MAPK/NF-κB signaling pathway.Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells.STK11 domain XI mutations: candidate genetic drivers leading to the development of dysplastic polyps in Peutz-Jeghers syndrome.Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells.The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells.Novel biodegradable HSAM nanoparticle for drug delivery.Detection of target nucleic acids and proteins by amplification of circularizable probes.High prevalence of HPV59 in cytologically abnormal cervical samples.Molecular Zipper: a fluorescent probe for real-time isothermal DNA amplification.BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice.Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay.Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.Anticancer activity of Scutellaria baicalensis and its potential mechanism.
P50
Q21132473-E81D3F9A-44C9-445C-842A-CF4D03F5F4D2Q27324419-6CE6F3B2-C648-4292-B9EA-8F9174C8EE6FQ30756909-0DFA5550-4096-4B10-A0E0-208F576BC258Q33758011-2848BA39-D778-4737-A44F-4BCD6B888935Q33785608-CBF29525-2834-496A-BED9-3623768C6AA3Q33865082-EAFD0052-6E62-40C4-B09D-B69B2A4E6BFAQ33947101-69159E00-98C1-4229-A407-47B84541E090Q34166698-1C5FF396-CFEF-448F-B332-FD23D8ECD55FQ34231561-E6B18A17-D86A-4BCE-AB31-F01B82C2B368Q34448168-E6BE5F1C-BD7F-420A-B0A7-16C15B2F0C72Q34506462-AACCE2BD-24A0-4354-B077-A6E43FAD0C4BQ34630490-9C4E5CE2-EB5F-4D8D-91A5-8B9BFAB7BC9CQ35016695-95771ED4-4D39-49ED-92BB-56798A4211FCQ35235854-36DFC8F4-82BE-4B51-B568-723C231A192CQ35584628-A499D1FE-8BFF-4835-A9C4-13AFC9A5DF17Q35837683-3ABE7970-0FEF-48AF-8AC1-BB10BDBD1786Q36568239-BA543472-4AEA-44B3-BE3D-F7E0065644D4Q36858170-8AFF82EF-A344-42DA-8192-681B3AE5A30CQ37294322-90A806B0-6A4B-4E46-A6F1-F5B6A6D4F73BQ37317578-B854C65E-A9B3-42C1-AC84-0CCBD8E988BEQ37428203-2644E632-8604-4F8C-BBB6-86485DE14D97Q37639929-D32A4F8D-E626-4883-BE05-9A09AACA8222Q38805922-8AAF77AD-43F6-4888-8EA9-7945EA79E91FQ38920087-8BC73A89-6F7E-4D28-8725-A380F68C07CEQ38954924-5368B440-EE53-4BE4-8154-1D82904F6271Q39077184-AF88D115-A7DC-4A6E-A691-805DFCD66774Q39226266-DD9742D6-39A1-4480-B308-A82F27FD8D4DQ39363633-9F164258-A5D7-49B3-98EF-60B0FE4AFD9AQ39377020-12730BED-2A2A-48B2-A0ED-034AF2722B96Q39542955-0940006A-CA71-4BED-BC06-19E6BC4A2C59Q39578351-8D041139-26F0-4A8F-9804-0127A49FED49Q39786097-9B408BC4-42DC-4558-9971-9A3E295778FDQ40307112-247D9C47-D5E2-4B38-977D-28AC027299FFQ40599245-6F526A3E-A2A4-4228-A979-1F68764ABC1CQ40960526-28C9B34A-A7E5-42B4-B111-F78BB98B1144Q41499904-5AC963C5-0C46-4ABA-962F-B3E93EAFCE5CQ41749880-9186DB59-6F69-48E8-878A-A1D11FBBEF84Q42943070-A8306942-97D2-49AE-877A-725E1B02C651Q43950147-69637A61-1296-48FB-953C-C252C623529AQ44241505-E8DF26D5-A81A-411E-AD72-977D90DE674B
P50
description
medical pathologist and oncologist
@en
name
David Y. Zhang
@ast
David Y. Zhang
@en
David Y. Zhang
@es
David Y. Zhang
@nl
type
label
David Y. Zhang
@ast
David Y. Zhang
@en
David Y. Zhang
@es
David Y. Zhang
@nl
altLabel
David Zhang
@en
prefLabel
David Y. Zhang
@ast
David Y. Zhang
@en
David Y. Zhang
@es
David Y. Zhang
@nl